Cancer Of the BReast Asanas Study (COBRA)

Recruiting N/A Interventional Study
Breast Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Female
Study type
Interventional
Purpose
Supportive Care
Participants needed
140 (estimated)
Sponsor
UMC Utrecht · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Rationale: Women with hormone-receptor positive breast cancer are usually prescribed endocrine therapy for a period of 5-10 years. This treatment reduces the risk of recurrence and improves overall survival in these women. Musculoskeletal complaints are a common (\~50%) negative consequence of endocrine treatment, which affects daily functioning and quality of life. These symptoms frequently resul…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Be diagnosed with oestrogen-receptor positive stage I-III breast cancer, * Use of aromatase inhibitors or Tamoxifen (\>4 months and will continue using it for at least six months), * Have finished primary treatment (chemotherapy, radiotherapy, surgery) for at least 12 weeks, *…
Contacts

Evelyn Monninkhof, Dr.

+31623786177

e.monninkhof@umcutrecht.nl

CONTACT

Stefanie Veenhuizen, MSc

+31631119129

s.g.a.veenhuizen@umcutrecht.nl

CONTACT